BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35321875)

  • 1. Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results.
    Van Hoovels L; Vander Cruyssen B; Sieghart D; Bonroy C; Nagy E; Pullerits R; Čučnik S; Dahle C; Heijnen I; Bernasconi L; Benkhadra F; Bogaert L; Van Den Bremt S; Van Liedekerke A; Vanheule G; Robbrecht J; Studholme L; Wirth C; Müller R; Kyburz D; Sjöwall C; Kastbom A; Ješe R; Jovancevic B; Kiss E; Jacques P; Aletaha D; Steiner G; Verschueren P; Bossuyt X
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35321875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
    Van Hoovels L; Jacobs J; Vander Cruyssen B; Van den Bremt S; Verschueren P; Bossuyt X
    Ann Rheum Dis; 2018 May; 77(5):667-677. PubMed ID: 29363510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
    Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
    Front Immunol; 2018; 9():876. PubMed ID: 29740454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
    Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
    Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
    Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
    Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IgG ACPA-IgM RF immune complexes were detected in rheumatoid arthritis patients positive for IgM ACPA.
    Haraguchi A; Yamada H; Kondo M; Okazaki K; Fukushi JI; Oyamada A; Yoshikai Y; Nakashima Y
    Clin Exp Rheumatol; 2018; 36(4):612-618. PubMed ID: 29465353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in Rheumatoid Arthritis - Laboratory and Clinical Perspectives.
    Rönnelid J; Turesson C; Kastbom A
    Front Immunol; 2021; 12():685312. PubMed ID: 34054878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA rheumatoid factor in rheumatoid arthritis.
    Van Hoovels L; Vander Cruyssen B; Sieghart D; Bonroy C; Nagy E; Pullerits R; Čučnik S; Dahle C; Heijnen I; Bernasconi L; Benkhadra F; Bogaert L; Van Den Bremt S; Van Liedekerke A; Vanheule G; Robbrecht J; Studholme L; Wirth C; Müller R; Kyburz D; Sjöwall C; Kastbom A; Ješe R; Jovancevic B; Kiss E; Jacques P; Aletaha D; Steiner G; Verschueren P; Bossuyt X
    Clin Chem Lab Med; 2022 Sep; 60(10):1617-1626. PubMed ID: 35790193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of autoimmune serology test results on RA classification and diagnosis.
    Van Hoovels L; Studenic P; Sieghart D; Steiner G; Bossuyt X; Rönnelid J
    J Transl Autoimmun; 2022; 5():100142. PubMed ID: 35036891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients.
    Meyer P; Ally M; Hodkinson B; Anderson R; Tikly M
    Afr Health Sci; 2018 Jun; 18(2):295-303. PubMed ID: 30602956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.
    Oka S; Higuchi T; Furukawa H; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S
    BMC Musculoskelet Disord; 2022 Jan; 23(1):46. PubMed ID: 35027028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis.
    Manca ML; Alunno A; D'Amato C; Bistoni O; Puxeddu I; Gerli R; Migliorini P; Pratesi F
    Joint Bone Spine; 2018 Jul; 85(4):441-445. PubMed ID: 28826660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance.
    Martinez-Prat L; Nissen MJ; Lamacchia C; Bentow C; Cesana L; Roux-Lombard P; Gabay C; Mahler M
    Front Immunol; 2018; 9():1113. PubMed ID: 29928272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior specificity of anti-citrullinated peptide antibodies in patients with chronic lymphocytic leukemia and arthritis.
    Brickmann K; Brezinschek RI; Yazdani-Biuki B; Graninger WB; Brezinschek HP
    Clin Exp Rheumatol; 2010; 28(6):888-91. PubMed ID: 21205465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis.
    Xie S; Li S; Chen B; Zhu Q; Xu L; Li F
    Clin Rheumatol; 2021 Nov; 40(11):4533-4543. PubMed ID: 34189672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of synthetic peptides for detection of anti-citrullinated protein antibodies in rheumatoid arthritis.
    Trier NH; Holm BE; Heiden J; Slot O; Locht H; Jensen B; Lindegaard H; Svendsen A; Nielsen CT; Jacobsen S; Theander E; Houen G
    J Immunol Methods; 2018 Mar; 454():6-14. PubMed ID: 29128424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to Citrullinated Protein Antigens, Rheumatoid Factor Isotypes and the Shared Epitope and the Near-Term Development of Clinically-Apparent Rheumatoid Arthritis.
    Bergstedt DT; Tarter WJ; Peterson RA; Feser ML; Parish MC; Striebich CC; Demoruelle MK; Moss L; Bemis EA; Norris JM; Holers VM; Edison JD; Thiele GM; Mikuls TR; Deane KD
    Front Immunol; 2022; 13():916277. PubMed ID: 35812446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of IgG antibodies targeting unmodified and corresponding citrullinated autoantigens in a multicenter national cohort of early arthritis in Germany.
    Vordenbäumen S; Brinks R; Schriek P; Lueking A; Richter JG; Budde P; Schulz-Knappe P; Zucht HD; Callhoff J; Schneider M
    Arthritis Res Ther; 2020 Jul; 22(1):167. PubMed ID: 32631453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use and utility of serologic tests for rheumatoid arthritis in primary care.
    Tenstad HB; Nilsson AC; Dellgren CD; Lindegaard HM; Rubin KH; Lillevang ST
    Dan Med J; 2020 Feb; 67(2):. PubMed ID: 32053486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-citrullinated peptide antibodies and rheumatoid factor isotypes in the diagnosis of rheumatoid arthritis: an assessment of combined tests.
    Infantino M; Manfredi M; Meacci F; Sarzi-Puttini P; Ricci C; Atzeni F; Benucci M
    Clin Chim Acta; 2014 Sep; 436():237-42. PubMed ID: 24892812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.